作者
Lane B Benes, Daniel J Brandt, Eric J Brandt, Michael H Davidson
发表日期
2018/12
来源
Current Cardiology Reports
卷号
20
页码范围
1-7
出版商
Springer US
简介
Purpose of the Review
To summarize advances in genomic medicine and anticipated future directions to improve cardiovascular risk reduction.
Recent Findings
Mendelian randomization and genome-wide association studies have given significant insights into the role of genetics in dyslipidemia and cardiovascular disease (CVD), with over 160 gene loci found to be associated with coronary artery disease to date. This has enabled the creation of genetic risk scores that have demonstrated improved risk prediction when added to clinical markers of CVD risk.
Summary
Incorporation of genomic data into clinical patient care is on the horizon. Genomic medicine is expected to offer improved risk assessment, determination of targeted treatment strategies, and improved detection of lipid disorders causal to CVD development …
学术搜索中的文章
LB Benes, DJ Brandt, EJ Brandt, MH Davidson - Current Cardiology Reports, 2018